What type of treatment is recommended for HIV-positive pregnant women?

For HIV-positive pregnant women, the recommended treatment is HIV prophylactic treatment. This approach is essential because it helps to reduce the viral load in the mother's body, which not only protects the health of the mother but also significantly decreases the risk of transmission of the virus to the fetus during pregnancy, labor, and breastfeeding.

Using antiretroviral therapy (ART) as part of prophylactic treatment ensures that the woman maintains better health outcomes throughout her pregnancy. It also leads to low levels of the virus in the blood, ideally achieving an undetectable viral load, which is crucial for preventing mother-to-child transmission (MTCT) of HIV.

In contrast, antiparasitic treatment, while important for certain infections, does not address HIV specifically. Symptomatic treatment focuses on alleviating symptoms rather than treating the underlying viral infection, and antidepressant treatment targets mental health rather than the physiological aspects of HIV management. Therefore, the focus on prophylactic treatment in the context of HIV in pregnancy is critical for both the mother and the child's health.